NxStage Medical, Inc. (NASDAQ:NXTM)

CAPS Rating: 2 out of 5

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

Recs

2
Player Avatar HelpU2Build (59.25) Submitted: 2/16/2010 5:16:52 PM : Outperform Start Price: $8.40 NXTM Score: -21.95

Outstanding product potential for reducing medical cost and increasing quality of life results.

Featured Broker Partners


Advertisement